Versicherungsmedizin最新文献

筛选
英文 中文
Our Language 我们的语言
Versicherungsmedizin Pub Date : 2022-02-22 DOI: 10.2307/j.ctv2b29sxn.46
{"title":"Our Language","authors":"","doi":"10.2307/j.ctv2b29sxn.46","DOIUrl":"https://doi.org/10.2307/j.ctv2b29sxn.46","url":null,"abstract":"","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68804916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[What do company health insurance plans provide?] 公司的健康保险计划提供什么?]
Versicherungsmedizin Pub Date : 2016-12-15
R Hamiki
{"title":"[What do company health insurance plans provide?]","authors":"R Hamiki","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Company health insurance plans are a voluntary employer benefit and an increasingly important part of company pension and benefits systems. They enable employers to invest in the health of their employees. They are also a useful modular complement to both statutory and private health insurance. Company health insurance plans allow employers to attract first-rate staff and to retain them for the long term. Employees, in turn, are provided with a variety of attractive additional benefits, for instance treatment by chief physicians, single or double-room hospital accommodation, additional aids and remedies, and a variety of screenings and medical check ups. It is expected that, in the next few years, company health insurance will become very widespread.</p>","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"68 4","pages":"180-1"},"PeriodicalIF":0.0,"publicationDate":"2016-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35558573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Assessment of prescriptive therapies and remedies - Experience and results]. [处方疗法和补救措施的评估-经验和结果]。
Versicherungsmedizin Pub Date : 2016-12-15
M Dörmann
{"title":"[Assessment of prescriptive therapies and remedies - Experience and results].","authors":"M Dörmann","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the years 2005-2015, a leading assessment institute conducted numerous assessments on behalf of two major German private health insurance companies concerning the necessity of prescriptive therapies and remedies. The findings are presented in this article, and the results vary significantly, depending on the prescriptive therapy assessed.</p>","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"68 4","pages":"176-9"},"PeriodicalIF":0.0,"publicationDate":"2016-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35558623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Can we transfer the mechanisms of the generics market to biosimilars?] 我们能否将仿制药市场的机制转移到生物仿制药上?]
Versicherungsmedizin Pub Date : 2016-12-15
Ch O Jacke, F Wild
{"title":"[Can we transfer the mechanisms of the generics market to biosimilars?]","authors":"Ch O Jacke,&nbsp;F Wild","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Personalized medicines such as biologics and their generic equivalents, biosimilars, are pouring onto the pharmaceutical markets. Data of 16 private health insurance companies were used to describe the market shares of selected biosimilars available in 2014 and 2015. The purpose of this study focuses on the question of whether market access of biosimilars will lead to a price competition of the expense of innovation competition. The results show that prescriptions of biosimilars made up 37% of total prescriptions in 2015 compared to 35% in 2014, and that their share of prescription costs went up from 21% to 23% in the same period. Price competition similar to that found in the generic markets has been established for erythropoietin and filgrastim. The same has not been observed for follitropin alfa and somatropin due to the limited number of competitors and products available at this stage. No definitive conclusions can be drown from the results at this stage. Time will tell whether it will be possible for physicians and individuals with private health insurance to fully leverage the savings potential of biosimilars while safeguarding patient safety.</p>","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"68 4","pages":"168-72"},"PeriodicalIF":0.0,"publicationDate":"2016-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35254561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The importance of biosimilars medicines for private and statutory health insurance]. [生物仿制药对私人和法定健康保险的重要性]。
Versicherungsmedizin Pub Date : 2016-12-15
B Bretthauer
{"title":"[The importance of biosimilars medicines for private and statutory health insurance].","authors":"B Bretthauer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Patented biopharmaceuticals generate huge costs for private and statutory health insurance. Exactly ten years ago, off-patent biopharmaceuticals, also referred to as 'biosimilars medicines', became available as a more cost-efficient and therapeutically equivalent alternative in Germany and Europe. Following their approval by all the relevant authorities, biosimilars medicines can therefore be applied in the same way as previously patented biopharmaceuticals.</p>","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"68 4","pages":"173-5"},"PeriodicalIF":0.0,"publicationDate":"2016-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35254562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Postvaccinal complication and medical malpractice law]. [疫苗后并发症和医疗事故法]。
Versicherungsmedizin Pub Date : 2016-06-01
A Posa, S Zierz
{"title":"[Postvaccinal complication and medical malpractice law].","authors":"A Posa,&nbsp;S Zierz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The case report involves a 38-year-old female patient with muscular atrophy, paresis and sensory deficits in the right upper limb following several vaccinations. A legal dispute ensued over whether medical malpractice could have caused the neurological deficits. Medical malpractice could not be confirmed. Even vaccinations administered correctly can lead to neurological impairment.</p>","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"69 2","pages":"67-9"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34726315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Potential for intervention of private health insurers in discharge management using the example of stroke patients]. [以中风患者为例,私营医疗保险公司在出院管理中的干预潜力]。
Versicherungsmedizin Pub Date : 2016-06-01
E Sterl, J Böhme
{"title":"[Potential for intervention of private health insurers in discharge management using the example of stroke patients].","authors":"E Sterl,&nbsp;J Böhme","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The study reveals that stroke patients today can still experience gaps in the provision of healthcare and fragmented therapy. This is often the case on transferral from the inpatient to outpatient sector, causing complications that could be avoided by means of good discharge management across all sectors. Private health insurance can actively support and positively influence the treatment process in the form of case management. Individual contact with stroke patients and their relatives allows for early planning and organisation of the next steps, and offers patients the support they need during a difficult phase of life.</p>","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"69 2","pages":"73-5"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34726317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Not Available]. (不可用)。
Versicherungsmedizin Pub Date : 2016-06-01
G-M Ostendorf
{"title":"[Not Available].","authors":"G-M Ostendorf","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"69 2","pages":"79-80"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34726320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Not Available]. (不可用)。
Versicherungsmedizin Pub Date : 2016-06-01
P Schwark
{"title":"[Not Available].","authors":"P Schwark","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"69 2","pages":"57"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34726312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Not Available]. (不可用)。
Versicherungsmedizin Pub Date : 2016-06-01
G-M Ostendorf
{"title":"[Not Available].","authors":"G-M Ostendorf","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77455,"journal":{"name":"Versicherungsmedizin","volume":"69 2","pages":"83"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34726323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书